|
2025-02-25 |
2025-02-21 |
VP
Vente planifiée
|
Morrell Martha
CHIEF MEDICAL OFFICER
Dirigeant
|
78 334
-48.9%
13,72
1 074 844 USD
|
78 334
-48.9%
|
13,72
|
1 074 844 USD
|
|
|
2025-02-20 |
2025-02-20 |
V
Vente
|
KCK LTD.
Actionnaire important
|
5 270 845
-100.0%
9,40
49 545 943 USD
|
5 270 845
-100.0%
|
9,40
|
49 545 943 USD
|
|
|
2025-01-31 |
2025-01-30 |
VP
Vente planifiée
|
Morrell Martha
CHIEF MEDICAL OFFICER
Dirigeant
|
200
-0.2%
15,00
3 000 USD
|
200
-0.2%
|
15,00
|
3 000 USD
|
|
|
2025-01-31 |
2025-01-29 |
VP
Vente planifiée
|
Morrell Martha
CHIEF MEDICAL OFFICER
Dirigeant
|
100
-0.1%
15,00
1 500 USD
|
100
-0.1%
|
15,00
|
1 500 USD
|
|
|
2025-01-28 |
2025-01-24 |
VP
Vente planifiée
|
Morrell Martha
CHIEF MEDICAL OFFICER
Dirigeant
|
3 200
-3.5%
15,01
48 032 USD
|
3 200
-3.5%
|
15,01
|
48 032 USD
|
|
|
2024-10-28 |
2024-10-25 |
V
Vente
|
KCK LTD.
Actionnaire important
|
223 991
-4.1%
5,45
1 221 042 USD
|
223 991
-4.1%
|
5,45
|
1 221 042 USD
|
|
|
2024-10-28 |
2024-10-23 |
V
Vente
|
KCK LTD.
Actionnaire important
|
147
-0.0%
6,02
885 USD
|
147
-0.0%
|
6,02
|
885 USD
|
|
|
2024-10-24 |
2024-10-22 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 082
-0.1%
6,09
24 853 USD
|
4 082
-0.1%
|
6,09
|
24 853 USD
|
|
|
2024-10-22 |
2024-10-21 |
V
Vente
|
KCK LTD.
Actionnaire important
|
3 720
-0.1%
6,10
22 679 USD
|
3 720
-0.1%
|
6,10
|
22 679 USD
|
|
|
2024-10-22 |
2024-10-18 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 878
-0.1%
6,29
30 692 USD
|
4 878
-0.1%
|
6,29
|
30 692 USD
|
|
|
2024-10-18 |
2024-10-17 |
V
Vente
|
KCK LTD.
Actionnaire important
|
3 294
-0.1%
6,28
20 686 USD
|
3 294
-0.1%
|
6,28
|
20 686 USD
|
|
|
2024-10-18 |
2024-10-16 |
V
Vente
|
KCK LTD.
Actionnaire important
|
6 900
-0.1%
6,57
45 336 USD
|
6 900
-0.1%
|
6,57
|
45 336 USD
|
|
|
2024-10-18 |
2024-10-15 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 017
-0.1%
6,50
26 098 USD
|
4 017
-0.1%
|
6,50
|
26 098 USD
|
|
|
2024-10-18 |
2024-10-14 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 031
-0.1%
6,54
26 360 USD
|
4 031
-0.1%
|
6,54
|
26 360 USD
|
|
|
2024-10-18 |
2024-10-11 |
V
Vente
|
KCK LTD.
Actionnaire important
|
2 572
-0.0%
6,35
16 320 USD
|
2 572
-0.0%
|
6,35
|
16 320 USD
|
|
|
2024-10-18 |
2024-10-10 |
V
Vente
|
KCK LTD.
Actionnaire important
|
2 504
-0.0%
6,12
15 317 USD
|
2 504
-0.0%
|
6,12
|
15 317 USD
|
|
|
2024-10-18 |
2024-10-09 |
V
Vente
|
KCK LTD.
Actionnaire important
|
3 123
-0.1%
6,10
19 065 USD
|
3 123
-0.1%
|
6,10
|
19 065 USD
|
|
|
2024-10-18 |
2024-10-08 |
V
Vente
|
KCK LTD.
Actionnaire important
|
6 000
-0.1%
6,43
38 552 USD
|
6 000
-0.1%
|
6,43
|
38 552 USD
|
|
|
2024-10-18 |
2024-10-07 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 910
-0.1%
6,66
32 687 USD
|
4 910
-0.1%
|
6,66
|
32 687 USD
|
|
|
2024-10-18 |
2024-10-04 |
V
Vente
|
KCK LTD.
Actionnaire important
|
5 757
-0.1%
6,92
39 830 USD
|
5 757
-0.1%
|
6,92
|
39 830 USD
|
|
|
2024-10-18 |
2024-10-03 |
V
Vente
|
KCK LTD.
Actionnaire important
|
3 318
-0.1%
6,97
23 115 USD
|
3 318
-0.1%
|
6,97
|
23 115 USD
|
|
|
2024-10-03 |
2024-10-02 |
V
Vente
|
KCK LTD.
Actionnaire important
|
3 843
-0.1%
6,87
26 401 USD
|
3 843
-0.1%
|
6,87
|
26 401 USD
|
|
|
2024-10-03 |
2024-10-01 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 882
-0.1%
6,77
33 051 USD
|
4 882
-0.1%
|
6,77
|
33 051 USD
|
|
|
2024-10-03 |
2024-09-30 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 749
-0.1%
6,73
31 961 USD
|
4 749
-0.1%
|
6,73
|
31 961 USD
|
|
|
2024-10-03 |
2024-09-27 |
V
Vente
|
KCK LTD.
Actionnaire important
|
5 059
-0.1%
6,63
33 541 USD
|
5 059
-0.1%
|
6,63
|
33 541 USD
|
|
|
2024-10-03 |
2024-09-26 |
V
Vente
|
KCK LTD.
Actionnaire important
|
5 821
-0.1%
6,62
38 535 USD
|
5 821
-0.1%
|
6,62
|
38 535 USD
|
|
|
2024-10-03 |
2024-09-25 |
V
Vente
|
KCK LTD.
Actionnaire important
|
5 858
-0.1%
6,60
38 663 USD
|
5 858
-0.1%
|
6,60
|
38 663 USD
|
|
|
2024-10-03 |
2024-09-23 |
V
Vente
|
KCK LTD.
Actionnaire important
|
282
-0.0%
7,54
2 126 USD
|
282
-0.0%
|
7,54
|
2 126 USD
|
|
|
2024-10-03 |
2024-09-20 |
V
Vente
|
KCK LTD.
Actionnaire important
|
765
-0.0%
7,50
5 738 USD
|
765
-0.0%
|
7,50
|
5 738 USD
|
|
|
2024-10-03 |
2024-09-13 |
V
Vente
|
KCK LTD.
Actionnaire important
|
1 993
-0.0%
7,59
15 127 USD
|
1 993
-0.0%
|
7,59
|
15 127 USD
|
|
|
2024-10-03 |
2024-09-06 |
V
Vente
|
KCK LTD.
Actionnaire important
|
11
-0.0%
7,50
83 USD
|
11
-0.0%
|
7,50
|
83 USD
|
|
|
2024-10-03 |
2024-09-04 |
V
Vente
|
KCK LTD.
Actionnaire important
|
14
-0.0%
7,50
105 USD
|
14
-0.0%
|
7,50
|
105 USD
|
|
|
2024-10-03 |
2024-09-03 |
V
Vente
|
KCK LTD.
Actionnaire important
|
2 093
-0.0%
7,60
15 907 USD
|
2 093
-0.0%
|
7,60
|
15 907 USD
|
|
|
2024-10-03 |
2024-08-30 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 314
-0.1%
7,76
33 477 USD
|
4 314
-0.1%
|
7,76
|
33 477 USD
|
|
|
2024-05-03 |
2024-05-03 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
4 674
-0.1%
14,03
65 576 USD
|
4 674
-0.1%
|
14,03
|
65 576 USD
|
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
8 842
-0.3%
14,01
123 876 USD
|
8 842
-0.3%
|
14,01
|
123 876 USD
|
|
|
2024-05-03 |
2024-05-01 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
15 690
-0.5%
14,02
219 974 USD
|
15 690
-0.5%
|
14,02
|
219 974 USD
|
|
|
2024-04-26 |
2024-04-24 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
1 781
-0.1%
14,06
25 041 USD
|
1 781
-0.1%
|
14,06
|
25 041 USD
|
|
|
2024-04-23 |
2024-04-23 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
21 791
-0.6%
14,29
311 393 USD
|
21 791
-0.6%
|
14,29
|
311 393 USD
|
|
|
2024-04-23 |
2024-04-22 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
24 609
-0.7%
14,05
345 756 USD
|
24 609
-0.7%
|
14,05
|
345 756 USD
|
|
|
2024-04-23 |
2024-04-19 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
18 253
-0.5%
14,02
255 907 USD
|
18 253
-0.5%
|
14,02
|
255 907 USD
|
|
|
2024-04-18 |
2024-04-18 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
2 623
-0.1%
14,06
36 879 USD
|
2 623
-0.1%
|
14,06
|
36 879 USD
|
|
|
2024-04-18 |
2024-04-17 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
300
-0.0%
14,15
4 245 USD
|
300
-0.0%
|
14,15
|
4 245 USD
|
|
|
2024-04-18 |
2024-04-16 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
14 069
-0.4%
14,01
197 107 USD
|
14 069
-0.4%
|
14,01
|
197 107 USD
|
|
|
2024-04-15 |
2024-04-12 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
23 101
-0.7%
14,42
333 116 USD
|
23 101
-0.7%
|
14,42
|
333 116 USD
|
|
|
2024-04-15 |
2024-04-11 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
461 899
-11.5%
14,49
6 692 917 USD
|
461 899
-11.5%
|
14,49
|
6 692 917 USD
|
|
|
2024-02-06 |
2024-02-05 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
3 446
-4.2%
15,17
52 278 USD
|
3 446
-4.2%
|
15,17
|
52 278 USD
|
|
|
2024-02-06 |
2024-02-02 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
14 143
-14.8%
15,07
213 122 USD
|
14 143
-14.8%
|
15,07
|
213 122 USD
|
|
|
2024-02-01 |
2024-02-01 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
663
-0.7%
15,04
9 971 USD
|
663
-0.7%
|
15,04
|
9 971 USD
|
|
|
2024-02-01 |
2024-01-31 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
1 923
-2.0%
15,08
28 990 USD
|
1 923
-2.0%
|
15,08
|
28 990 USD
|
|
|
2024-02-01 |
2024-01-30 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
11 262
-10.3%
15,10
170 004 USD
|
11 262
-10.3%
|
15,10
|
170 004 USD
|
|
|
2024-01-26 |
2024-01-25 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
1
-0.0%
15,00
15 USD
|
1
-0.0%
|
15,00
|
15 USD
|
|
|
2024-01-26 |
2024-01-24 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
827
-0.8%
15,03
12 426 USD
|
827
-0.8%
|
15,03
|
12 426 USD
|
|
|
2023-12-28 |
2023-12-27 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
13 300
-10.8%
10,12
134 648 USD
|
13 300
-10.8%
|
10,12
|
134 648 USD
|
|
|
2023-12-28 |
2023-12-26 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
102
-0.1%
10,00
1 020 USD
|
102
-0.1%
|
10,00
|
1 020 USD
|
|
|
2023-12-22 |
2023-12-20 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
2 730
-2.2%
10,14
27 695 USD
|
2 730
-2.2%
|
10,14
|
27 695 USD
|
|
|
2023-12-07 |
2023-12-06 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
11 005
-8.0%
8,16
89 773 USD
|
11 005
-8.0%
|
8,16
|
89 773 USD
|
|
|
2023-12-01 |
2023-12-01 |
V
Vente
|
KCK LTD.
Actionnaire important
|
3 241
-0.1%
8,73
28 294 USD
|
3 241
-0.1%
|
8,73
|
28 294 USD
|
|
|
2023-12-01 |
2023-11-30 |
V
Vente
|
KCK LTD.
Actionnaire important
|
7 282
-0.1%
8,84
64 373 USD
|
7 282
-0.1%
|
8,84
|
64 373 USD
|
|
|
2023-12-01 |
2023-11-29 |
V
Vente
|
KCK LTD.
Actionnaire important
|
5 644
-0.1%
8,72
49 216 USD
|
5 644
-0.1%
|
8,72
|
49 216 USD
|
|
|
2023-11-29 |
2023-11-28 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 681
-0.1%
8,75
40 959 USD
|
4 681
-0.1%
|
8,75
|
40 959 USD
|
|
|
2023-11-29 |
2023-11-27 |
V
Vente
|
KCK LTD.
Actionnaire important
|
6 490
-0.1%
8,96
58 150 USD
|
6 490
-0.1%
|
8,96
|
58 150 USD
|
|
|
2023-10-04 |
2023-10-03 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
700
-0.0%
9,02
6 314 USD
|
700
-0.0%
|
9,02
|
6 314 USD
|
|
|
2023-10-04 |
2023-10-02 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
7 614
-0.2%
9,08
69 135 USD
|
7 614
-0.2%
|
9,08
|
69 135 USD
|
|
|
2022-11-23 |
2022-11-22 |
A
Achat
|
Accelmed Partners II L.P.
Actionnaire important
|
62 398
+1.4%
1,50
93 535 USD
|
62 398
+1.4%
|
1,50
|
93 535 USD
|
|
|
2022-11-23 |
2022-11-21 |
A
Achat
|
Accelmed Partners II L.P.
Actionnaire important
|
327 893
+8.1%
1,50
491 512 USD
|
327 893
+8.1%
|
1,50
|
491 512 USD
|
|
|
2022-06-09 |
2022-06-08 |
VP
Vente planifiée
|
Ridley Irina
General Counsel and Secretary
Dirigeant
|
2 500
-3.9%
5,78
14 445 USD
|
2 500
-3.9%
|
5,78
|
14 445 USD
|
|
|
2022-03-01 |
2022-02-28 |
VP
Vente planifiée
|
Ridley Irina
General Counsel and Secretary
Dirigeant
|
1 470
-18.1%
7,54
11 082 USD
|
1 470
-18.1%
|
7,54
|
11 082 USD
|
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Norton Evan
Administrateur non-exécutif
|
588 235
+inf%
17,00
9 999 995 USD
|
588 235
+inf%
|
17,00
|
9 999 995 USD
|
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
ORBIMED ADVISORS LLC
Actionnaire important
|
235 000
+inf%
17,00
3 995 000 USD
|
235 000
+inf%
|
17,00
|
3 995 000 USD
|
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Accelmed Partners II L.P.
Actionnaire important
|
588 235
+inf%
17,00
9 999 995 USD
|
588 235
+inf%
|
17,00
|
9 999 995 USD
|
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Fischer Frank M
Administrateur non-exécutif
|
50 000
+115.5%
17,00
850 000 USD
|
50 000
+115.5%
|
17,00
|
850 000 USD
|
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Garfield Greg Shaw
Administrateur non-exécutif
|
13 235
+51.7%
17,00
224 995 USD
|
13 235
+51.7%
|
17,00
|
224 995 USD
|
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Ridley Irina
General Counsel and Secretary
Dirigeant
|
2 352
+inf%
17,00
39 984 USD
|
2 352
+inf%
|
17,00
|
39 984 USD
|
|
